Meeting
2011 ASCO Annual Meeting
Impact of conditioning regimen on outcome of 2-year disease-free survivors of autologous stem cell transplantation (ASCT) for Hodgkin lymphoma (HL).
Authors
B. M. William
University of Nebraska Medical Center, Omaha, NE
B. M. William , F. R. Loberiza Jr., V. Whalen , P. J. Bierman , G. Bociek , J. Vose , J. O. Armitage
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lymphoma and Plasma Cell Disorders
Track
Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
Sub Track
Lymphoma
Citation
J Clin Oncol 29: 2011 (suppl; abstr 8043)
Abstract #
8043
Poster Bd #
44G
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Role of high-dose chemotherapy with autologous stem cell transplantation for primary central nervous system lymphoma: A systematic review.
First Author: Shaha Nabeel
Poster
2016 ASCO Annual Meeting
High-dose versus standard-dose rituximab with BEAM in autologous stem cell transplantation (SCT) for relapsed aggressive b-cell non-Hodgkin’s lymphomas (NHL).
First Author: Samer Ali Srour
Poster
2013 ASCO Annual Meeting
Efficacy of radioimmunotherapy-based conditioning with high-dose chemotherapy and autologous stem cell transplantation for transformed lymphoma.
First Author: Amrita Y. Krishnan
Poster
2024 ASCO Breakthrough
Outcome analysis of autologous stem cell transplantation in refractory and relapsed Hodgkin lymphoma: Insights from a North African single-institution study.
First Author: Marouane Maaroufi